APPARATUS FOR TREATING TINNITUS THROUGH STIMULATING MULTIPLE ACUPOINTS WITH MULTI-ELECTRODE ELECTRIC PULSE BASED ON BLUETOOTH CONTROL AND ACUPOINT STIMULATING METHOD USING THE SAME

Abstract

An apparatus for treating tinnitus through stimulating multiple acupoints with a multi-electrode electric pulse. A control terminal controls a first MCU micro-control module and the second MCU micro-control module to allow the second MCU micro-control module to output a variety of different pulse signals, and the different pulse signals are respectively output to an electric-pulse output circuit and an electric-pulse conversion circuit. The pulse signal output to the electric-pulse output circuit is a carrier signal. The pulse signal output to the electric-pulse conversion circuit is converted to a modulating wave by the electric-pulse conversion circuit. The modulating wave and the carrier signal are both output to the electrical-pulse output circuit. After a modulation, a transcutaneous electric-pulse stimulation signal is output by an output port, and is transmitted to an electrode sheet attached to the corresponding acupoint on human body through an electrode wire to stimulate the acupoint.

Claims

1. An apparatus for treating tinnitus through stimulating multiple acupoints with a multi-electrode electric pulse based on Bluetooth control, comprising: a control terminal; a main body; an electrode wire; and an electrode sheet group connected to the electrode wire; wherein the electrode sheet group comprises at least three electrode sheets; the main body comprises a control module, a power supply module and an output module; the power supply module and the output module are electrically connected to the control module, respectively; the control module comprises a first microcontroller unit (MCU) micro-control circuit and a Bluetooth communication circuit; the Bluetooth communication circuit is electrically connected to the first MCU micro-control circuit; the first MCU micro-control circuit is connected to the power supply module; the first MCU micro-control circuit is wirelessly connected to the control terminal through the Bluetooth communication circuit; the output module comprises a second MCU micro-control circuit, a voltage regulation circuit, an electric-pulse conversion circuit, an electric-pulse output circuit and an output port; the second MCU micro-control circuit is electrically connected to the first MCU micro-control circuit, the voltage regulation circuit, the electric-pulse conversion circuit and the electric-pulse output circuit; the voltage regulation circuit is electrically connected to the electric-pulse output circuit and the electric-pulse conversion circuit; the electric-pulse output circuit is electrically connected to the electric-pulse conversion circuit and the output port; and the electrode wire is connected to the output port; the first MCU micro-control circuit is configured to control the second MCU micro-control circuit to output a pulse signal to the electric-pulse conversion circuit, so as to output a modulating wave through conversion by the electric-pulse conversion circuit; the pulse signal output from the second MCU micro-control circuit to the electric-pulse output circuit is a carrier signal; a transcutaneous electric-pulse stimulation signal output by the electric-pulse output circuit is an electric pulse of the carrier signal after modulated by the modulating wave; the modulating wave is a low-frequency pulse signal which is mainly characterized by frequency f.sub.low, period T.sub.low and pulse width τ.sub.low; the carrier signal is a mid-frequency pulse signal; the mid-frequency pulse signal is a bipolar signal; the mid-frequency pulse signal is mainly characterized by frequency f.sub.mid, period T.sub.mid, pulse width τ.sub.mid, time difference Δτ between an end of a negative mid-frequency pulse signal and a start of a positive pulse and a mid-frequency pulse signal duty cycle D; the transcutaneous electric-pulse stimulation signal is a rectangular voltage pulse or a rectangular current pulse; the transcutaneous electric-pulse stimulation signal is characterized by f.sub.low, T.sub.low, τ.sub.low, f.sub.mid, T.sub.mid, τ.sub.mid, Δτ, the mid-frequency pulse signal duty cycle D, maximum amplitude A.sub.max and minimum amplitude A.sub.min; parameters meet the following conditions: $f_{\mathrm{low}}=0.1\sim 100\mathrm{Hz};f_{\mathrm{low}}=\frac{1}{T_{\mathrm{low}}};$ $f_{\mathrm{mid}}=1\sim 100\mathrm{KHz};f_{\mathrm{mid}}=\frac{1}{T_{\mathrm{mid}}};$ f.sub.low=nf.sub.mid; wherein n is a positive integer;
τ.sub.low>2τ.sub.mid+Δτ; wherein Δτ=T.sub.mid(1-2D); τ.sub.low=0.1˜1 ms; τ.sub.mid=D.Math.T.sub.mid; D=1%˜50%; $\frac{A_{\min }}{A_{\max }}=0\sim 1;$ and the control terminal is configured to control the first MCU micro-control circuit and the second MCU micro-control circuit to allow the electric-pulse output circuit to output a corresponding transcutaneous electric-pulse stimulation signal to an electrode sheet of the at least three electrode sheets according to a time series combination.

2. The apparatus of claim 1, wherein the electrode sheet group comprises an electrode sheet A, an electrode sheet B and an electrode sheet C; the time series combination is shown as follows:
[τ.sub.AB−τ−τ.sub.BC−τ−τ.sub.AC−τ].sub.T.sub.0;  time series 1:
[|τ.sub.AB−τ|.sub.T.sub.1−|τ.sub.BC−τ|.sub.T.sub.2−|τ.sub.AC−τ|.sub.T.sub.3]; and  time series 2:
[|τ.sub.AB−τ|.sub.T.sub.1−|τ.sub.AC−τ|.sub.T.sub.3−|τ.sub.BC−τ|.sub.T.sub.2];  time series 3: wherein τ.sub.AB is time for the electrode sheet A and the electrode sheet B to output an electric pulse, and is 3-5 seconds; τ.sub.BC is time for the electrode sheet B and the electrode sheet C to output an electric pulse, and is 3-5 seconds; τ.sub.Ac is time for the electrode sheet A and the electrode sheet C to output an electric pulse, and is 3-5 seconds; τ is time when the electrode sheet A, the electrode sheet B and the electrode sheet C have no output, and is 1-2 seconds; T.sub.0 is time of an output loop of the electrode sheet A, the electrode sheet B and the electrode sheet C in sequence in the time series 1, and is 45-90 min; T.sub.1 is time of an output loop of the electrode sheet A and the electrode sheet B in the time series 2 and the time series 3, and is 15-30 min; T.sub.2 is time of an output loop of the electrode sheet B and the electrode sheet C in the time series 2 and the time series 3, and is 15-30 min; and T.sub.3 is time of an output loop of the electrode sheet A and the electrode sheet C in the time series 2 and the time series 3, and is 15-30 min.

3. The apparatus of claim 1, wherein f.sub.low=50 Hz; f.sub.mid=1 KHz; n=20; T.sub.low=20 ms; T.sub.mid=1 ms; τ.sub.low=800 us; τ.sub.mid=200 us; D=20%; and Δτ=300 us.

4. The apparatus of claim 2, wherein f.sub.low=50 Hz; f.sub.mid=1 KHz; n=20; T.sub.low=20 ms; T.sub.mid=1 ms; τ.sub.low=800 us; τ.sub.mid=200 us; D=20%; and Δτ=300 us.

5. The apparatus of claim 3, wherein the power supply module comprises a charging port, a charging management circuit, a rechargeable battery, a power path management circuit and a power conversion circuit electrically connected in sequence; the power supply module further comprises a charging indication circuit; the charging indication circuit is electrically connected to the charging management circuit; and the power path management circuit is electrically connected to the first MCU micro-control circuit.

6. The apparatus of claim 4, wherein the power supply module comprises a charging port, a charging management circuit, a rechargeable battery, a power path management circuit and a power conversion circuit electrically connected in sequence; the power supply module further comprises a charging indication circuit; the charging indication circuit is electrically connected to the charging management circuit; and the power path management circuit is electrically connected to the first MCU micro-control circuit.

7. The apparatus of claim 5, wherein the control module further comprises a power measuring circuit, a switch circuit and a work indication circuit; the power measuring circuit, the switch circuit and the work indication circuit are electrically connected to the first MCU micro-control circuit; and the power measuring circuit is electrically connected to the rechargeable battery.

8. The apparatus of claim 6, wherein the control module further comprises a power measuring circuit, a switch circuit and a work indication circuit; the power measuring circuit, the switch circuit and the work indication circuit are electrically connected to the first MCU micro-control circuit; and the power measuring circuit is electrically connected to the rechargeable battery.

9. The apparatus of claim 7, wherein the control terminal is a smart phone.

10. The apparatus of claim 8, wherein the control terminal is a smart phone.

11. An acupoint stimulating method using the apparatus of claim 1, comprising: placing three electrode sheets of the apparatus on Zhongzhu acupoint, Tinggong acupoint and Yifeng acupoint of human body, respectively; and outputting, by the electric-pulse output circuit, a corresponding transcutaneous electric-pulse stimulation signal to an electrode sheet of the three electrode sheets according to a time series combination.

12. An acupoint stimulating method using the apparatus of claim 2, comprising: placing three electrode sheets of the apparatus on Zhongzhu acupoint, Tinggong acupoint and Yifeng acupoint of human body, respectively; and outputting, by the electric-pulse output circuit, a corresponding transcutaneous electric-pulse stimulation signal to an electrode sheet of the three electrode sheets according to a time series combination.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0046] FIG. 1 schematically depicts a structure of a therapeutic apparatus in accordance with an embodiment of the present disclosure;

[0047] FIG. 2 is a circuit diagram of a main body in accordance with an embodiment of the present disclosure;

[0048] FIG. 3 is a schematic diagram of a mid-frequency transcutaneous electric-pulse stimulation signal in accordance with an embodiment of the present disclosure;

[0049] FIG. 4 is a partial enlarged view of FIG. 3;

[0050] FIG. 5 schematically depicts a modulation of a mid-frequency transcutaneous electric-pulse stimulation signal in accordance with an embodiment of the present disclosure;

[0051] FIG. 6 schematically depicts time series 1 of an electrode sheet group;

[0052] FIG. 7 schematically depicts time series 2 of the electrode sheet group;

[0053] FIG. 8 schematically depicts time series 3 of the electrode sheet group;

[0054] FIG. 9 is a circuit diagram of a control module in FIG. 2;

[0055] FIG. 10 is a circuit diagram of a power supply module in FIG. 2;

[0056] FIG. 11 is a circuit diagram of a second MCU micro-control circuit in FIG. 2;

[0057] FIG. 12 is a circuit diagram of an electric-pulse output circuit in FIG. 2;

[0058] FIG. 13 is a circuit diagram of the electric-pulse conversion circuit in FIG. 2;

[0059] FIG. 14 is a circuit diagram of the voltage regulation circuit in FIG. 2; and

[0060] FIG. 15 is a circuit diagram of a Type-C output port circuit in FIG. 2.

DETAILED DESCRIPTION OF EMBODIMENTS

[0061] As shown in FIG. 1, the present disclosure provides an apparatus for treating tinnitus through stimulating multiple acupoints with a multi-electrode electric pulse based on Bluetooth control. The apparatus includes a main body 10, a smart phone 40 as a control terminal, an electrode wire 30 and an electrode sheet group 20 connected to the electrode wire 30. The electrode wire 30 is connected to the main body 10. The electrode sheet group 20 includes an electrode sheet A, an electrode sheet B and an electrode sheet C.

[0062] As shown in FIG. 2, the main body 10 includes a control module 110, and a power supply module 120 and an output module 130 electrically connected to the control module 110, respectively.

[0063] The power supply module 120 includes a charging port 121, a charging management circuit 122, a rechargeable battery 123, a power path management circuit 125 and a power conversion circuit 126 electrically connected in sequence, and the power supply module 120 further includes a charging indication circuit 124 electrically connected to the charging management circuit 122.

[0064] The output module 130 includes a second microcontroller unit (MCU) micro-control circuit 131, an electric-pulse output circuit 132, a Type-C output port circuit 133, a voltage regulation circuit 134, and an electric-pulse conversion circuit 135. The electric-pulse output circuit 132, the voltage regulation circuit 134 and the electric-pulse conversion circuit 135 are respectively electrically connected to the second MCU micro-control circuit 131. The voltage regulation circuit 134 is electrically connected to the electric-pulse output circuit 132 and the electric-pulse conversion circuit 135. The electric-pulse output circuit 132 is electrically connected to the electric-pulse conversion circuit 135. The Type-C output port circuit 133 is electrically connected to the electric-pulse output circuit 132. The electrode wire 30 is connected to the Type-C output port circuit 133.

[0065] The control module 110 includes a first MCU micro-control circuit 113, a power detection circuit 111, a Bluetooth communication circuit 112, a switch circuit 114 and a work indication circuit 115. The power detection circuit 111, the Bluetooth communication circuit 112, the switch circuit 114 and the work indication circuit 115 are respectively electrically connected to the first MCU micro-control circuit 113. The first MCU micro-control circuit 113 is electrically connected to the power path management circuit 125 and the second MCU micro-control circuit 131. The first MCU micro-control circuit 113 and the second MCU micro-control circuit 131 realize communication control through a universal synchronous/asynchronous receiver/transmitter (USART) serial port. The power detection circuit 111 is electrically connected to the rechargeable battery 123.

[0066] As shown in FIGS. 3-4, the smart phone 40 communicates with the Bluetooth communication circuit 112 and transmits a control signal to the first MCU micro-control circuit 113. The first MCU micro-control circuit 113 controls the second MCU micro-control circuit 131 to output a pulse signal to the electric-pulse conversion circuit 135. After the conversion by the electric-pulse conversion circuit 135, the electric-pulse conversion circuit 135 outputs a modulating wave as shown in the dotted line in FIGS. 3 and 4.

[0067] The pulse signal output from the second MCU micro-control circuit 131 to the electric-pulse output circuit 132 is a carrier signal. The electric-pulse output circuit 132 outputs a low-frequency or a mid-frequency transcutaneous electric-pulse stimulation signal, which is an electric pulse of the carrier signal after modulated by the modulating wave. The solid lines shown in FIGS. 3 and 4 are the mid-frequency transcutaneous electric-pulse stimulation signal (the low-frequency transcutaneous electric-pulse stimulation signal is not shown). The Type-C output port circuit 133 selects and switches the output signal, and outputs it to the electrode wire 30 and the electrode sheet group 20. The output signal is transmitted to the human skin through the electrode sheet A, the electrode sheet B and the electrode sheet C those are attached to the human skin.

[0068] The second MCU micro-control circuit 131 controls the voltage regulation circuit 134 to output voltages of different intensities, provides a high voltage source for the electric-pulse output circuit 132 and the electric-pulse conversion circuit 135, and controls the intensity of the mid-frequency or low-frequency transcutaneous electric-pulse stimulation signal through the smart phone 40.

[0069] The modulating wave is a low-frequency pulse signal, and the low-frequency pulse signal is mainly characterized by frequency f.sub.low, period T.sub.low and pulse width τ.sub.low.

[0070] The carrier signal is a mid-frequency pulse signal, and the mid-frequency pulse signal is a bipolar signal. The mid-frequency pulse signal is mainly characterized by frequency f.sub.mid, period T.sub.mid, pulse width τ.sub.mid, time difference Δτ between an end of a negative mid-frequency pulse signal and a start of a positive pulse and a mid-frequency pulse signal duty cycle D.

[0071] The mid-frequency or low-frequency transcutaneous electric-pulse stimulation signal is a rectangular voltage pulse or a rectangular current pulse.

[0072] The main characteristic parameters of mid-frequency or low-frequency transcutaneous electric-pulse stimulation signal include f.sub.low, T.sub.low, τ.sub.low, f.sub.mid, T.sub.mid, τ.sub.mid, Δτ, the mid-frequency pulse signal duty cycle D, maximum amplitude A.sub.max and minimum amplitude A.sub.min;

[0073] Those parameters meet the following conditions.

[00007]$f_{\mathrm{low}}=0.1\sim 100\mathrm{Hz};f_{\mathrm{low}}=\frac{1}{T_{\mathrm{low}}};$$f_{\mathrm{mid}}=1\sim 100\mathrm{KHz};f_{\mathrm{mid}}=\frac{1}{T_{\mathrm{mid}}};$ [0074] f.sub.low=nf.sub.mid; where n is any positive integer;

τ.sub.low>2τ.sub.mid+Δτ; where

[0075] Δτ=T.sub.mid(1-2D); τ.sub.low=0.1˜1 ms; τ.sub.mid=D.Math.T.sub.mid; D=1%˜50%;

[00008]$\frac{A_{\min }}{A_{\max }}=0\sim 1.$

[0076] In some embodiments, f.sub.low=50 Hz; f.sub.mid=1 KHz; n=20; T.sub.low=20 ms; T.sub.mid=1 ms; τ.sub.low=800 us; ϕ.sub.mid=200 us; D=20%; Δτ=300 us.

[0077] It should be noted that FIGS. 3 and 4 of this embodiment only show schematic diagrams of the mid-frequency transcutaneous electric-pulse stimulation signal, that is, when the ratio of the minimum amplitude to the maximum amplitude is non-zero:

[00009]$\frac{A_{\min }}{A_{\max }}\ne 0.$

When the ratio of the minimum amplitude to the maximum amplitude of the transcutaneous electric-pulse stimulation signal is 0:

[00010]$\frac{A_{\min }}{A_{\max }}=0,$

the transcutaneous electric-pulse stimulation signal is the low-frequency transcutaneous electric-pulse stimulation signal (not shown).

[0078] FIG. 5 is a modulation process of the mid-frequency transcutaneous electric-pulse stimulation signal.

[0079] The first MCU micro-control circuit 113 and the second MCU micro-control circuit 131 can be controlled through the smart phone 40, such that the electric-pulse output circuit 132 can freely output the mid-frequency or low-frequency transcutaneous electric-pulse stimulation signals. When used by the crowd, the action area needs to be deepened, and the mid-frequency transcutaneous electric-pulse stimulation signal is used to replace the low-frequency transcutaneous electric-pulse stimulation signal, maintaining the effect of low frequency parameters and providing a better stimulation effect.

[0080] As shown in FIGS. 6-8, in order to achieve different stimulating effects, the smart phone 40 controls the first MCU micro-control circuit 113 and the second MCU micro-control circuit 131, such that the electric-pulse output circuit 132 outputs corresponding mid-frequency or low-frequency transcutaneous electric-pulse stimulation signal to the three electrode sheets according to different time series combinations. The time series are shown as follows:

[τ.sub.AB−τ−τ.sub.BC−τ−τ.sub.AC−τ].sub.T.sub.0;  time series 1:

[|τ.sub.AB−τ|.sub.T.sub.1−|τ.sub.BC−τ|.sub.T.sub.2−|τ.sub.AC−τ|.sub.T.sub.3]; and  time series 2:

[|τ.sub.AB−τ|.sub.T.sub.1−|τ.sub.AC−τ|.sub.T.sub.3−|τ.sub.BC−τ|.sub.T.sub.2];  time series 3:

[0081] where τ.sub.AB is time for the electrode sheet A and the electrode sheet B to output an electric pulse, and is 3-5 seconds;

[0082] τ.sub.BC is time for the electrode sheet B and the electrode sheet C to output an electric pulse, and is 3-5 seconds;

[0083] τ.sub.AC is time for the electrode sheet A and the electrode sheet C to output an electric pulse, and is 3-5 seconds;

[0084] τ is time when the electrode sheet A, the electrode sheet B and the electrode sheet C have no output, and is 1-2 seconds;

[0085] T.sub.0 is time of an output loop of the electrode sheet A, the electrode sheet B and the electrode sheet C in sequence in the time series 1, and is 45-90 min;

[0086] T.sub.1 is time of an output loop of the electrode sheet A and the electrode sheet B in the time series 2 and the time series 3, and is 15-30 min;

[0087] T.sub.2 is time of an output loop of the electrode sheet B and the electrode sheet C in the time series 2 and the time series 3, and is 15-30 min;

[0088] T.sub.3 is time of an output loop of the electrode sheet A and the electrode sheet C in the time series 2 and the time series 3, and is 15-30 min.

[0089] As shown in FIGS. 2 and 10, the power supply module 120 supplies power for the control module 110 and the output module 130. The charging management circuit 122 can use various charging management chips. In some embodiments, the U1 chip is a charging management chip TP404X (Nanjing Top Power ASIC Co., Ltd., China) or a charging management chip LTC404X (Linear Technology Corporation, US). The chips have a function of automatically terminating the charging cycle and recycling recharging. L1 and C1 can filter out the instantaneous surge when the charging power source is plugged in to protect the power supply module 120.

[0090] The charging indication circuit 124 indicates a charging state of the system. A charging state is represented by red, and a fully charged state is represented by green.

[0091] The power path management circuit 125 uses a P-channel enhanced metal-oxide-semiconductor (MOS) field-effect transistor to manage the power supply of the system. When the rechargeable battery 123, such as a polymer lithium battery, is over-discharged and working with a load, a protection board of the rechargeable battery 123 will be in a stopped state, such that the rechargeable battery 123 is failed to charge. In addition, frequent charging/discharging and performing the charging and discharging at the same time will affect the service life of the rechargeable battery 123. Therefore, when the rechargeable battery 123 is charged by the power path management circuit 125, the therapeutic apparatus is only powered by a power supply connected to the charging port 121.

[0092] When the charging port 121 is not connected to a charging power source, the MOS field-effect transistor is turned on and the therapeutic apparatus is powered by the rechargeable battery 123. When the charging port 121 is connected to a charging power source, the MOS field-effect transistor Q1 is turned off and the therapeutic apparatus is powered by the charging power source. D4 is a voltage regulator tube to avoid damage to a charging management chip when the charging port 121 is connected to a power source greater than a maximum input voltage of the charging management chip. The charge management chip is the charge management chip of the charging management circuit 122.

[0093] The power conversion circuit 126 converts a voltage of the rechargeable battery 123 into an operating voltage of the control module 110 and the output module 130.

[0094] As shown in FIGS. 2 and 9, the control module 110 includes the first MCU micro-control circuit 113, a power measuring circuit 111, a work indication circuit 115, the switch circuit 114 and the Bluetooth communication circuit 112. A MCU chip (U17) in the first MCU micro-control circuit 113 is a CC254X Bluetooth chip (Texas instruments incorporated, US). The Bluetooth communication circuit 112 includes a 2.4 G Bluetooth antenna and a balun. The balun is a packaged LFB182G45BG2D280 balun chip or a balun circuit matched by capacitance and inductance. The balun converts a single-ended signal into a differential signal, and forms a communication connection between the control module 110 and the smart phone 40.

[0095] The switch circuit 114 and the work indication circuit 115 is configured to control the switch of the control module 110 and indicate a working state thereof. The power measuring circuit 111 is configured to measure the power of the rechargeable battery 123.

[0096] FIG. 11 is a circuit diagram of the second MCU micro-control circuit 131, in which the MCU chip is U11 (STM32F070X) and outputs pulse signals (PWM4, PWM5), pulse signals (PWM2, PWM3) and a voltage regulation control signals (regulating) to the corresponding electric-pulse output circuit 132, the electric-pulse conversion circuit 135 and the voltage regulation circuit 134.

[0097] FIG. 12 is a circuit diagram of the electric-pulse output circuit 132, in which QN4 and QN6 are NPN transistors, and QN5 is a PNP transistor. The electric-pulse output circuit 132 can output the mid-frequency or low-frequency transcutaneous electric-pulse stimulation signal that meets the aforementioned characterization parameters. Output signals (elec1_1, elec1_2) are selected and switched by SW4 and SW5 (such as a LTC20X multi-channel analog switch of Analog Devices, Inc., US) in the Type-C output port circuit 133 (the switching control can be controlled by Sw4 ctrl and Sw5 ctrl signals output by the second MCU micro-control circuit 131), and then are output by a Type-C port to the electrode sheet A, the electrode sheet B and the electrode sheet C (elec_A, elec_B, elec_C). The Type-C output port circuit 133 is shown in FIG. 15.

[0098] FIG. 13 is a circuit diagram of the electric-pulse conversion circuit 135, in which QN1 and QN2 are NPN transistors, and QN3 is a PNP transistor. A pulse signal output by the second MCU micro-control circuit 131 is converted into a modulating wave and output to the electric-pulse output circuit 132.

[0099] FIG. 14 is a circuit diagram of the voltage regulation circuit 134. The second MCU micro-control circuit 131 outputs a regulating control signal (regulating) to U3 (MT and LT chips), and regulates an output power Vh to the electric-pulse output circuit 132 and the electric-pulse conversion circuit 135.

[0100] The control terminal used herein is the smart phone 40, which sets the main characteristic parameters of the carrier signal and the modulating wave through an installed application. The characteristic parameters include the mid-frequency transcutaneous electric-pulse stimulation signal or low-frequency transcutaneous electric-pulse stimulation signal, stimulation intensity and stimulation time. The mid-frequency transcutaneous electric-pulse stimulation signal or low-frequency transcutaneous electric-pulse stimulation signal is output by the electric-pulse output circuit 132, and stimulates relevant acupoints such as Zhongzhu acupoint and Tinggong acupoint and Yifeng acupoint of human body through the electrode sheet group 20. The stimulation effect can be optimized through controlling different time series combination of the electrode sheet group 20. It should be noted that the control terminal of the therapeutic apparatus includes but not is limited to various intelligent electronic devices such as tablet computers, smart bracelets and artificial intelligence devices, and remote control instruments controlled by Bluetooth communication.

[0101] It should be noted that the presented embodiments are only preferred embodiments of the present disclosure. The embodiments are illustrative, and not intended to limit the scope of the present disclosure. Modifications and replacements made by those skilled in the art without departing from the spirit of this disclosure should fall within the scope of the present disclosure.